DRI HEALTHCARE TRUST (DHT-UN.CA) Fundamental Analysis & Valuation

TSX:DHT-UN • CA23344H1091

Current stock price

16.25 CAD
-0.17 (-1.04%)
Last:

This DHT-UN.CA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

4

1. DHT-UN.CA Profitability Analysis

1.1 Basic Checks

  • DHT-UN had positive earnings in the past year.
  • In the past year DHT-UN had a positive cash flow from operations.
  • The reported net income has been mixed in the past 5 years: DHT-UN reported negative net income in multiple years.
  • In the past 5 years DHT-UN always reported a positive cash flow from operatings.
DHT-UN.CA Yearly Net Income VS EBIT VS OCF VS FCFDHT-UN.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 2024 2025 0 50M -50M 100M

1.2 Ratios

  • DHT-UN has a Return On Assets of -5.35%. This is comparable to the rest of the industry: DHT-UN outperforms 50.00% of its industry peers.
  • DHT-UN has a Return On Equity (-11.51%) which is comparable to the rest of the industry.
  • DHT-UN has a Return On Invested Capital of 4.25%. This is in the better half of the industry: DHT-UN outperforms 71.88% of its industry peers.
  • The Average Return On Invested Capital over the past 3 years for DHT-UN is significantly below the industry average of 8.03%.
  • The 3 year average ROIC (2.87%) for DHT-UN is below the current ROIC(4.25%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA -5.35%
ROE -11.51%
ROIC 4.25%
ROA(3y)1.76%
ROA(5y)2.41%
ROE(3y)1.4%
ROE(5y)2.6%
ROIC(3y)2.87%
ROIC(5y)2.78%
DHT-UN.CA Yearly ROA, ROE, ROICDHT-UN.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 2024 2025 0 5 -5 10 -10 15

1.3 Margins

  • DHT-UN has a better Operating Margin (26.77%) than 90.63% of its industry peers.
  • In the last couple of years the Operating Margin of DHT-UN has grown nicely.
  • The Profit Margin and Gross Margin are not available for DHT-UN so they could not be analyzed.
Industry RankSector Rank
OM 26.77%
PM (TTM) N/A
GM N/A
OM growth 3Y23.29%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
DHT-UN.CA Yearly Profit, Operating, Gross MarginsDHT-UN.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 2024 2025 0 20 -20 40

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

3

2. DHT-UN.CA Health Analysis

2.1 Basic Checks

  • DHT-UN has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
  • DHT-UN has less shares outstanding than it did 1 year ago.
  • DHT-UN has a worse debt/assets ratio than last year.
DHT-UN.CA Yearly Shares OutstandingDHT-UN.CA Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 2024 2025 10M 20M 30M 40M 50M
DHT-UN.CA Yearly Total Debt VS Total AssetsDHT-UN.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 2024 2025 200M 400M 600M 800M

2.2 Solvency

  • Based on the Altman-Z score of 1.02, we must say that DHT-UN is in the distress zone and has some risk of bankruptcy.
  • Looking at the Altman-Z score, with a value of 1.02, DHT-UN is in the better half of the industry, outperforming 68.75% of the companies in the same industry.
  • The Debt to FCF ratio of DHT-UN is 4.43, which is a neutral value as it means it would take DHT-UN, 4.43 years of fcf income to pay off all of its debts.
  • The Debt to FCF ratio of DHT-UN (4.43) is better than 68.75% of its industry peers.
  • DHT-UN has a Debt/Equity ratio of 0.95. This is a neutral value indicating DHT-UN is somewhat dependend on debt financing.
  • The Debt to Equity ratio of DHT-UN (0.95) is worse than 71.88% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.95
Debt/FCF 4.43
Altman-Z 1.02
ROIC/WACC0.54
WACC7.87%
DHT-UN.CA Yearly LT Debt VS Equity VS FCFDHT-UN.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 2025 100M 200M 300M 400M

2.3 Liquidity

  • DHT-UN has a Current Ratio of 1.19. This is a normal value and indicates that DHT-UN is financially healthy and should not expect problems in meeting its short term obligations.
  • DHT-UN has a Current ratio of 1.19. This is in the lower half of the industry: DHT-UN underperforms 75.00% of its industry peers.
  • A Quick Ratio of 1.19 indicates that DHT-UN should not have too much problems paying its short term obligations.
  • With a Quick ratio value of 1.19, DHT-UN perfoms like the industry average, outperforming 53.13% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.19
Quick Ratio 1.19
DHT-UN.CA Yearly Current Assets VS Current LiabilitesDHT-UN.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2024 2025 20M 40M 60M 80M 100M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

6

3. DHT-UN.CA Growth Analysis

3.1 Past

  • The Earnings Per Share has been growing slightly by 4.15% over the past year.
  • Measured over the past 5 years, DHT-UN shows a small growth in Earnings Per Share. The EPS has been growing by 6.33% on average per year.
  • The Revenue has been growing slightly by 2.28% in the past year.
  • Measured over the past years, DHT-UN shows a very strong growth in Revenue. The Revenue has been growing by 29.36% on average per year.
EPS 1Y (TTM)4.15%
EPS 3Y6.33%
EPS 5YN/A
EPS Q2Q%1.32%
Revenue 1Y (TTM)2.28%
Revenue growth 3Y29.36%
Revenue growth 5YN/A
Sales Q2Q%-0.94%

3.2 Future

  • DHT-UN is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 16.69% yearly.
  • The Revenue is expected to grow by 12.98% on average over the next years. This is quite good.
EPS Next Y1.3%
EPS Next 2Y8.83%
EPS Next 3Y25.28%
EPS Next 5Y16.69%
Revenue Next Year3.88%
Revenue Next 2Y3.92%
Revenue Next 3Y5.54%
Revenue Next 5Y12.98%

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
DHT-UN.CA Yearly Revenue VS EstimatesDHT-UN.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 100M 200M 300M 400M
DHT-UN.CA Yearly EPS VS EstimatesDHT-UN.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 1 2 3 4

More info and screens

Find the best growth stocksShow best growing peers

8

4. DHT-UN.CA Valuation Analysis

4.1 Price/Earnings Ratio

  • DHT-UN is valuated cheaply with a Price/Earnings ratio of 5.18.
  • 84.38% of the companies in the same industry are more expensive than DHT-UN, based on the Price/Earnings ratio.
  • DHT-UN is valuated cheaply when we compare the Price/Earnings ratio to 26.21, which is the current average of the S&P500 Index.
  • A Price/Forward Earnings ratio of 5.10 indicates a rather cheap valuation of DHT-UN.
  • Based on the Price/Forward Earnings ratio, DHT-UN is valued cheaply inside the industry as 90.63% of the companies are valued more expensively.
  • When comparing the Price/Forward Earnings ratio of DHT-UN to the average of the S&P500 Index (23.10), we can say DHT-UN is valued rather cheaply.
Industry RankSector Rank
PE 5.18
Fwd PE 5.1
DHT-UN.CA Price Earnings VS Forward Price EarningsDHT-UN.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, DHT-UN is valued a bit cheaper than 78.13% of the companies in the same industry.
  • Based on the Price/Free Cash Flow ratio, DHT-UN is valued cheaper than 84.38% of the companies in the same industry.
Industry RankSector Rank
P/FCF 5.9
EV/EBITDA 7.14
DHT-UN.CA Per share dataDHT-UN.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 -5 10

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates DHT-UN does not grow enough to justify the current Price/Earnings ratio.
  • DHT-UN's earnings are expected to grow with 25.28% in the coming years. This may justify a more expensive valuation.
PEG (NY)3.99
PEG (5Y)N/A
EPS Next 2Y8.83%
EPS Next 3Y25.28%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

5

5. DHT-UN.CA Dividend Analysis

5.1 Amount

  • DHT-UN has a Yearly Dividend Yield of 4.57%, which is a nice return.
  • Compared to an average industry Dividend Yield of 0.40, DHT-UN pays a better dividend. On top of this DHT-UN pays more dividend than 100.00% of the companies listed in the same industry.
  • DHT-UN's Dividend Yield is rather good when compared to the S&P500 average which is at 1.89.
Industry RankSector Rank
Dividend Yield 4.57%

5.2 History

  • DHT-UN has been paying a dividend for over 5 years, so it has already some track record.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
DHT-UN.CA Yearly Dividends per shareDHT-UN.CA Yearly Dividends per shareYearly Dividends per share 2021 2022 2023 2024 2025 2026 0.2 0.4 0.6 0.8 1

5.3 Sustainability

DPN/A
EPS Next 2Y8.83%
EPS Next 3Y25.28%
DHT-UN.CA Yearly Income VS Free CF VS DividendDHT-UN.CA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2021 2022 2023 2024 2025 0 50M -50M 100M

More info and screens

Find the best dividend stocksShow peers with best dividend

DHT-UN.CA Fundamentals: All Metrics, Ratios and Statistics

DRI HEALTHCARE TRUST

TSX:DHT-UN (4/7/2026, 7:00:00 PM)

16.25

-0.17 (-1.04%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)03-03
Earnings (Next)05-11
Inst Owners51.66%
Inst Owner ChangeN/A
Ins Owners0.97%
Ins Owner ChangeN/A
Market Cap893.91M
Revenue(TTM)188.92M
Net Income(TTM)-50.47M
Analysts80
Price Target22.7 (39.69%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 4.57%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-Date03-31
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)4.66%
Min EPS beat(2)-4.46%
Max EPS beat(2)13.79%
EPS beat(4)2
Avg EPS beat(4)-2.8%
Min EPS beat(4)-21.52%
Max EPS beat(4)13.79%
EPS beat(8)5
Avg EPS beat(8)4.54%
EPS beat(12)7
Avg EPS beat(12)13.08%
EPS beat(16)9
Avg EPS beat(16)67.86%
Revenue beat(2)2
Avg Revenue beat(2)11.77%
Min Revenue beat(2)6.93%
Max Revenue beat(2)16.61%
Revenue beat(4)2
Avg Revenue beat(4)5.63%
Min Revenue beat(4)-0.64%
Max Revenue beat(4)16.61%
Revenue beat(8)5
Avg Revenue beat(8)11.32%
Revenue beat(12)9
Avg Revenue beat(12)22.15%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)2.98%
PT rev (3m)2.78%
EPS NQ rev (1m)-26.52%
EPS NQ rev (3m)-28.15%
EPS NY rev (1m)0%
EPS NY rev (3m)-1.19%
Revenue NQ rev (1m)5.37%
Revenue NQ rev (3m)5.41%
Revenue NY rev (1m)3.25%
Revenue NY rev (3m)3.26%
Valuation
Industry RankSector Rank
PE 5.18
Fwd PE 5.1
P/S 3.4
P/FCF 5.9
P/OCF 5.85
P/B 1.47
P/tB N/A
EV/EBITDA 7.14
EPS(TTM)3.14
EY19.32%
EPS(NY)3.18
Fwd EY19.6%
FCF(TTM)2.76
FCFY16.95%
OCF(TTM)2.78
OCFY17.11%
SpS4.78
BVpS11.09
TBVpS-8.58
PEG (NY)3.99
PEG (5Y)N/A
Graham Number27.99
Profitability
Industry RankSector Rank
ROA -5.35%
ROE -11.51%
ROCE 5.91%
ROIC 4.25%
ROICexc 4.47%
ROICexgc 100.55%
OM 26.77%
PM (TTM) N/A
GM N/A
FCFM 57.68%
ROA(3y)1.76%
ROA(5y)2.41%
ROE(3y)1.4%
ROE(5y)2.6%
ROIC(3y)2.87%
ROIC(5y)2.78%
ROICexc(3y)3.05%
ROICexc(5y)3.04%
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)3.99%
ROCE(5y)3.9%
ROICexgc growth 3Y91.89%
ROICexgc growth 5YN/A
ROICexc growth 3Y42.55%
ROICexc growth 5YN/A
OM growth 3Y23.29%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0.2
Health
Industry RankSector Rank
Debt/Equity 0.95
Debt/FCF 4.43
Debt/EBITDA 2.73
Cap/Depr 0.97%
Cap/Sales 0.52%
Interest Coverage 250
Cash Conversion 72.08%
Profit Quality N/A
Current Ratio 1.19
Quick Ratio 1.19
Altman-Z 1.02
F-Score3
WACC7.87%
ROIC/WACC0.54
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)4.15%
EPS 3Y6.33%
EPS 5YN/A
EPS Q2Q%1.32%
EPS Next Y1.3%
EPS Next 2Y8.83%
EPS Next 3Y25.28%
EPS Next 5Y16.69%
Revenue 1Y (TTM)2.28%
Revenue growth 3Y29.36%
Revenue growth 5YN/A
Sales Q2Q%-0.94%
Revenue Next Year3.88%
Revenue Next 2Y3.92%
Revenue Next 3Y5.54%
Revenue Next 5Y12.98%
EBIT growth 1Y16.2%
EBIT growth 3Y59.49%
EBIT growth 5YN/A
EBIT Next Year140.54%
EBIT Next 3Y57.03%
EBIT Next 5Y34.01%
FCF growth 1Y-4.36%
FCF growth 3Y12.04%
FCF growth 5YN/A
OCF growth 1Y-3.49%
OCF growth 3Y12.38%
OCF growth 5YN/A

DRI HEALTHCARE TRUST / DHT-UN.CA Fundamental Analysis FAQ

What is the ChartMill fundamental rating of DRI HEALTHCARE TRUST (DHT-UN.CA) stock?

ChartMill assigns a fundamental rating of 5 / 10 to DHT-UN.CA.


What is the valuation status for DHT-UN stock?

ChartMill assigns a valuation rating of 8 / 10 to DRI HEALTHCARE TRUST (DHT-UN.CA). This can be considered as Undervalued.


What is the profitability of DHT-UN stock?

DRI HEALTHCARE TRUST (DHT-UN.CA) has a profitability rating of 4 / 10.


What is the financial health of DRI HEALTHCARE TRUST (DHT-UN.CA) stock?

The financial health rating of DRI HEALTHCARE TRUST (DHT-UN.CA) is 3 / 10.